Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VKA”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Large-scale testing (Phase 3)Ended earlyNCT02618577
What this trial is testing

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Who this might be right for
Atrial High Rate Episodes
Atrial Fibrillation Network 2,608
Not applicableStudy completedNCT01029743
What this trial is testing

Xarelto Regulatory Post-Marketing Surveillance

Who this might be right for
Venous Thromboembolism
Bayer 3,388
Large-scale testing (Phase 3)Study completedNCT02664649
What this trial is testing

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis

Who this might be right for
Symptomatic Aortic StenosisEligible for Transcatheter Aortic Valve Replacement
Assistance Publique - Hôpitaux de Paris 1,510
Not applicableStudy completedNCT03532724
What this trial is testing

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

Who this might be right for
Self Management of Oral Anticoagulation With VKA Therapy
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 927
Testing effectiveness (Phase 2)Study completedNCT01533441
What this trial is testing

Vitamin K2 Intervention in Patients With Vitamin K Antagonists

Who this might be right for
Thrombosis
Danisco 50
Not applicableEnded earlyNCT03715725
What this trial is testing

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 70,000
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableStudy completedNCT02319460
What this trial is testing

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Who this might be right for
Hemorrhage
CSL Behring 2,238
Testing effectiveness (Phase 2)WithdrawnNCT04002011
What this trial is testing

DOAC Versus VKA After Cardiac Surgery

Who this might be right for
Anticoagulant-induced Bleeding
Laval University
Not applicableStudy completedNCT02240667
What this trial is testing

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,506
Not applicableStudy completedNCT02596230
What this trial is testing

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 7,797
Post-approval studies (Phase 4)Study completedNCT01727453
What this trial is testing

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

Who this might be right for
Acute Gastrointestinal Bleeding
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Not applicableStudy completedNCT02611635
What this trial is testing

Atrial Fibrillation Patient Preference Study

Who this might be right for
Atrial Fibrillation
Bayer 382
Not applicableStudy completedNCT04117048
What this trial is testing

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

Who this might be right for
Vitamine K Antagonist (VKA) TreatmentInternational Normalized Ratio (INR) Measure at HomeThromboembolic Pathology
Medicalps 128
Not applicableUnknownNCT02706080
What this trial is testing

Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

Who this might be right for
Antithrombotic Agents
University Hospital, Clermont-Ferrand 10
Post-approval studies (Phase 4)Study completedNCT03064035
What this trial is testing

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

Who this might be right for
Acute Bleeding on Long-Term Anticoagulation TherapyHemorrhageSignificant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)+1 more
HealthPartners Institute 79
Large-scale testing (Phase 3)Study completedNCT00062803
What this trial is testing

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Sanofi
Very early researchNot Yet RecruitingNCT07011095
What this trial is testing

DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

Who this might be right for
Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)
Population Health Research Institute 100
Not applicableStudy completedNCT01362933
What this trial is testing

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Who this might be right for
NeoplasmsVenous Thromboembolism
Floralis 502
Load More Results